Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The ...

Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, cases are starting to go up in much of the country now. But exactly how many ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

Two new COVID-19 variants are spreading across the country and doctors in Connecticut are expecting they could bring an uptick in cases.

Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

The HK gov't has announced that it will stop sponsoring private doctors to provide free Covid-19 oral antiviral pills from July 29, as the coronavirus disease "has become a common respiratory viral ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.